| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.55▲ | 1.55▲ | 1.55▼ | 1.58▼ | 1.36▲ |
| MA10 | 1.55▲ | 1.55▲ | 1.56▼ | 1.49▲ | 1.23▲ |
| MA20 | 1.55▲ | 1.56▼ | 1.57▼ | 1.36▲ | 1.03▲ |
| MA50 | 1.56▼ | 1.57▼ | 1.53▲ | 1.19▲ | 0.77▲ |
| MA100 | 1.56▼ | 1.51▲ | 1.41▲ | 0.97▲ | 0.91▲ |
| MA200 | 1.57▼ | 1.39▲ | 1.31▲ | 0.76▲ | 1.17▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.001▼ | -0.007▼ | 0.021▲ | 0.054▲ |
| RSI | 49.466▼ | 47.687▼ | 49.769▼ | 68.013▲ | 76.914▲ |
| STOCH | 47.222 | 44.244 | 33.333 | 84.987▲ | 79.926 |
| WILL %R | -50.000 | -64.706 | -58.333 | -20.455▲ | -11.392▲ |
| CCI | 81.667 | -4.204 | -16.492 | 75.546 | 181.127▲ |
|
Tuesday, September 23, 2025 04:23 PM
Lineage Cell Therapeutics, Inc. (NYSE:LCTX) is a clinical-stage biotech company developing allogeneic “off-the-shelf” cell therapies for neurological and ophthalmic disorders.
|
|
Friday, September 12, 2025 10:43 PM
Discover Lineage Cell Therapeutics' breakthroughs in cell therapy for macular degeneration, diabetes & hearing loss.
|
|
Friday, August 29, 2025 04:28 PM
1 Day LCTX -3.31% DJIA -0.20% Russell 2K -0.50% Health Care/Life Sciences -0.42% ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/25 | 1.54 | 1.59 | 1.52 | 1.55 | 1,240,800 |
| 24/09/25 | 1.59 | 1.625 | 1.50 | 1.60 | 1,309,614 |
| 23/09/25 | 1.62 | 1.64 | 1.55 | 1.59 | 1,232,500 |
| 22/09/25 | 1.47 | 1.64 | 1.47 | 1.62 | 1,966,200 |
| 19/09/25 | 1.58 | 1.58 | 1.46 | 1.53 | 1,859,000 |
| 18/09/25 | 1.43 | 1.62 | 1.40 | 1.55 | 3,581,900 |
| 17/09/25 | 1.39 | 1.42 | 1.35 | 1.39 | 1,151,500 |
| 16/09/25 | 1.37 | 1.42 | 1.32 | 1.38 | 1,552,478 |
| 15/09/25 | 1.35 | 1.36 | 1.28 | 1.35 | 1,639,591 |
| 12/09/25 | 1.29 | 1.42 | 1.27 | 1.34 | 3,107,400 |
|
|
||||
|
|
||||
|
|